Carolina Blood and Cancer Center

Carolina Blood and Cancer Care Associates (CBCCA) is a private oncology and hematology practice based in Rock Hill, South Carolina, that also serves as a prominent clinical research site. Founded in 2003 by CEO Dr. Kashyap Patel, the center provides comprehensive cancer care, including infusion therapy, immunotherapy, and oral oncology medications. CBCCA is recognized for its leadership in value-based care through the Oncology Care Model (OCM) and its "No One Left Alone" (NOLA) initiative, which targets health disparities in rural populations. The practice actively participates in Phase 1-3 clinical trials in collaboration with major pharmaceutical sponsors such as Amgen, Eli Lilly, and Bristol Myers Squibb.